Skip to content
Pharmaceutical Consulting, Regulatory Services, CEE
Services for drug and medical device companies
  • HOME
  • ABOUT US
  • PRESENCE BY COUNTRY
  • NEWS & ANALYTICS
  • CONTACT
enquiries@groveonline.com
  • HOME
  • ABOUT US
  • PRESENCE BY COUNTRY
  • NEWS & ANALYTICS
  • CONTACT

Yearly Archives: 2021

You are here:
  1. Home
  2. 2021

AMENDMENTS TO THE HEALTHCARE BUDGET PLAN IN POLAND

UncategorizedBy wpusername919614. December 2021

The Polish Government and the National Health Fund made amendments to the healthcare budget plan.

TRANSITION TO DIGITAL HEALTH NETWORK IN THE WESTERN BALKANS

Allgemein, UncategorizedBy wpusername919625. November 2021

At the 4th Western Balkan Digital Summit (11-13 October 2021, Podgorica, Montenegro), attended by representatives from the Western Balkan (WB) countries, WHO Regional Director, Dr Hans Hanri P. Kluge, made several strategic statements regarding development of the healthcare system in the Western Balkan region.

THE POLISH GOVERNMENT TO INCREASE HEALTHCARE SPENDING

UncategorizedBy wpusername91961. November 2021

An amendment to the law on publicly financed health care services, recently published in Journal of Laws of the Republic of Poland, envisages a gradual increase on healthcare spending from 5,75% of GDP in 2022 to 6,8% of GDP in 2026.

E-PIL PROJECT ANNOUNCED BY THE BALTIC REGULATORY AGENCIES

UncategorizedBy wpusername919612. October 2021

The e-PIL pilot project seeks to assess whether the introduction of electronic package leaflets (e-PILs) instead of printed labels with the view to ensure the safe use of hospital medicinal products and increase their availability.

HEALTHCARE DISTRIBUTION IN POLAND

AllgemeinBy wpusername919624. February 2021

The healthcare distribution sector in Poland has undergone considerable changes in recent years with consolidation and privatization driving change and leading wholesale players maximising national reach and market share.

PRICING AND REIMBURSEMENT POLICY CONSTRAINTS IN THE CEE REGION

AllgemeinBy wpusername919624. February 2021

Cost containment measures including price and reimbursement cuts are putting pharmaceutical manufactures under increased pressure and tougher market conditions are evident in Central and Eastern Europe. The current reimbursement environment in many CEE countries continues to pose challenges for all pharma market players, including producers and distributors of medicinal products alike.

Reform of pharmaceutical regulation in Kazakhstan

AllgemeinBy wpusername919624. February 2021

As of the end of 2017, active work on legislation change and update is going on in Kazakhstan in the area of healthcare and pharmaceutical business. Such legislative activity is aimed at harmonizing the laws of the Republic of Kazakhstan

Russia and Bulgaria signed cooperation agreement

AllgemeinBy wpusername919624. February 2021

Last week, on July 10, 2018, in Sofia VladislavShestakov–Director of the State Institute of Drugs and Good Practices, Deputy Head of the State GMP Inspectorate met with Professor AssenaStoimenova, Executive Director of the Bulgarian Drug Agency (Medicines Agency of the Bulgarian Health Ministry).

Aurobindo Pharma to acquire Apotex’ businesses in Poland, Czech Republic, the Netherlands, Spain and Belgium

AllgemeinBy wpusername919624. February 2021

Aurobindo Pharma announced that its wholly owned step-down subsidiary, Agile Pharma B. V. (Netherlands) has entered into an agreement on 13 July 2018 to acquire commercial operations and certain supporting infrastructure in five European countries viz. the Netherlands, Belgium, Spain, Poland and

Slovenia and Romania are the Fastest Growing Markets in Europe

AllgemeinBy wpusername919624. February 2021

Whilst the latest European Commission 2018 economic growth forecast for the EU stands at 2.3%, a large group of Eastern European countries clearly outpaces its European peers. Slovenia, Romania and Bulgaria lead the pack as shown on the chart below. Growth in the above CEE countries is forecast to

→12→
Go to Top